Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016
Background: Proton-pump inhibitors (PPIs) are among the most prescribed medicines worldwide and concern about their long-term use is growing. We used dispensing claims for every person in Australia dispensed publicly subsidized PPIs between 2013 and 2016 to determine the incidence and prevalence of...
Main Authors: | Benjamin Daniels, Sallie-Anne Pearson, Nicholas A. Buckley, Claudia Bruno, Helga Zoega |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-03-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/1756284820913743 |
Similar Items
-
Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia
by: Jonathan Brett, et al.
Published: (2018-12-01) -
Proton-pump inhibitors among adults: a nationwide drug-utilization study
by: Óskar Ö. Hálfdánarson, et al.
Published: (2018-05-01) -
Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia
by: Jianyun Wu, et al.
Published: (2020-05-01) -
Risks of Squamous Cell Carcinoma of The Lip and Cutaneous Melanoma in Older Australians Using Hydrochlorothiazide (HTCZ)
by: Benjamin Daniels, et al.
Published: (2020-12-01) -
Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early through late stage HER2-positive breast cancer (HER2BC)
by: Benjamin Daniels, et al.
Published: (2017-04-01)